Inherited catalase deficiency: Is it benign or a factor in various age related disorders?

Mutation Research - Reviews in Mutation Research

Volumn 753, Issue 2, 2013, Pages 147-154

  Góth, László ^a   Nagy, Teréz ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Acatalasemia; Age related diseases; Atherosclerosis; Diabetes; Hypocatalasemia; Neoplasms

Indexed keywords

APOLIPOPROTEIN B; CATALASE; GLUTAMINE; GLUTATHIONE PEROXIDASE; HISTIDINE; HYDROGEN PEROXIDE; RASBURICASE;

APOPTOSIS; ARTERIOSCLEROSIS; BREAST CARCINOMA; CATALASE DEFICIENCY; CELL VOLUME; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA MODIFICATION; DNA POLYMORPHISM; EXON; GENE TARGETING; GENETIC DISORDER; HEMICOLECTOMY; HEMOLYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; MASTECTOMY; METHEMOGLOBINEMIA; MISSENSE MUTATION; MOUTH LESION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PERITONEAL FIBROSIS; PHAGOCYTE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; RNA TRANSLATION; VITILIGO;

ANIMALIA; MUS;

EID: 84887022354     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2013.08.002     Document Type: Review

References (85)

1. Putnam C.D., Arvai A.S., Bourne Y., Tailner J.A. Active and inhibited catalase structures: ligand and NAPH binding and catalytic mechanism. J. Mol. Biol. 2000, 296:295-309.
2. Diaz A., Loewen P.C., Fita I., Carpena X. Thirty years of heme catalases structural biology. Arch. Biochem. Biophys. 2012, 525:102-110.
3. 2 removing enzyme in human erythrocytes. Blood 1997, 90:4973-4978.
4. Masuoka N., Wakimoto M., Ubuka T., Nakano T. Spectrophotometric determination of hydrogen peroxide: catalase activity and rates of hydrogen peroxide removal by erythrocytes. Clin. Chim. Acta 1996, 254:101-112.
5. Agar N.S., Sadrzadeh S.M., Hallaway P.E., Eaton J.W. Erythrocyte catalase. A somatic oxidant defense?. J. Clin. Invest. 1986, 77:319-321.
6. Khan A.U., Wilson T. Reactive oxygen species as cellular messengers. Chem. Biol. 1995, 2:439-445.
7. Dickinson B.C., Chang C.J. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol. 2011, 7:504-511.
8. Bashan N., Kosan J., Kacho I., Ovadia H., Rudich A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Phys. Rev. 2009, 89:27-71.
9. Afanasev I. Signaling reactive oxygen species in diabetes mellitus. Oxid. Med. Cell Longev. 2010, 3:361-373.
10. Cohen P. The twentieth century struggle to decipher insulin signaling. Nat. Rev. Mol. Cell Biol. 2006, 7:967-973.
11. Evans J.L., Maddux B.A., Goldfine I.D. The molecular basis for oxidative stress-induced insulin resistance. Antiox. Redox Signal. 2005, 7:1040-1052.
12. Goldstein B.J., Kalyankar M., Wu X. Redox paradox-insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005, 54:311-321.
13. Chetboun M., Abitbol G., Rozenberg K., Rozenfeld H., Deutsch A., Sampson S.R., Rosenzweigh T. Maintenance of redox state and pancreatic beta-cell function: role of leptin and adiponectin. J. Cell. Biochem. 2012, 113:1966-1976.
14. Veal E., Day A. Hydrogen peroxide as a signaling molecule. Antiox. Redox Signal. 2011, 15:147-151.
15. 2. Biol. Chem. 1999, 274:25078-25084.
16. Góth L., Eaton J.W. Hereditary catalase deficiency and increased risk of diabetes. Lancet 2000, 356:1820-1821.
17. Góth L. Catalase deficiency and type 2 diabetes. Diab. Care 2008, 31:e93.
18. Olejnicka B.T., Andersson A., Tryberg B., Dalen H., Brunk U.T. Beta-cells, oxidative stress, lysosomal stability, and apoptotic/necrotic cell death. Antiox. Redox Signal. 1999, 1:305-515.
19. Vlassara H., Striker G.E. AGE restriction in diabetes mellitus: a paradigm shift. Nat. Rev. Endocrinol. 2011, 7:526-539.
20. Fan X., Sell D.R., Zhang J., Nemet I., Theves M., Lu J., Strauch C., Halushka M.K., Monnier V.M. Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: a comparative analysis. Free Radic. Biol. Med. 2010, 49:847-856.
21. Milton N.G.N., Harris J.R. Polymorphism of amyloid-β fibrils and its effect on human erythrocyte catalase binding. Micron 2009, 40:800-810.
22. Milton N.G.N., Harris J.R. Human islet amyloid polypeptide fibril binding catalase: a transmission electron microscopy and microplate study. Sci. World J. 2012, 10:879-893.
23. Hur J., Sullivan K.A., Schuyler A.D., Hong Y., Pande M., States D.J., Jagadis H.V., Feldman E.L. Literature-based discovery of diabetes- and ROS-related targets. BMC Med. Gen. 2010, 3:44-60.
24. Takahara S., Ogata M. Metabolism in Japanese acatalasemia with special reference to superoxide and glutahione peroxidase. Biochemical and Medical Aspects of Active Oxygen 1977, 275-292. University of Tokyo Press, Tokyo. I. Hayakawa, K. Asada (Eds.).
25. Aebi H., Wiss S.R. Acatalasemia. The metabolic and molecular basis of inherited diseases 1997, Mc Graw Hill, New York. 4th ed. J.B. Stanbury, J.B. Wingaarden, D.S. Frederickson (Eds.).
26. Eaton J.W., Mu M., Acatalasemia The metabolic and molecular bases of inherited diseases 1995, 2. Mc Graw Hill, New York. 2nd ed.
27. Ogata M., Wang D.H., Ogino K. Mammalian acatalasemia: the perspectives of bioinformatics and genetic toxicology. Acta Med. Okayama 2008, 62.
28. Takahara S. Progressive oral gangrene due to lack of catalase in the blood (acatalasemia). Lancet 1952, 2:1101-1104.
29. Feinstein R.N., Howard J., Braun J.T., Seaholm J.E. Acatalasemic and hypocatalasemic mouse mutants. Genetics 1966, 53:924-933.
30. Shaffer J.B., Preston K.E. Molecular analysis of an acatalasemic mouse mutant. Biochem. Biophys. Res. Commun. 1990, 173:1043-1050.
31. Wang D.-H., Tsutsui K., Sano K., Masuoka N., Kira S. cDNA cloning and expression of mutant catalase from the hypocatalasemic mouse: comparison with acatalasemic mutant. Biochim. Biophys. Acta 2001, 1922:217-220.
32. Ho Y.-S., Xiong Y., Ma W., Spector A., Ho D.S. Mice lacking catalase develop normally but show differential sensitivity to other oxidant tissue injury. The J. Biol. Chem. 2004, 279:32804-32812.
33. Takemoto K., Tanaka M., Iwata H., Nishihara R., Ishihara K., Wang D-H. Low catalase activity in blood is associated with the diabetes caused by alloxan. Clin. Chim. Acta 2009, 407:43-46.
34. Kikumoto Y., Sugiyama H., Inoue T., Morinaga H., Takiue K., Kitagawa M., Fukuoka N., Saeki M., Maeshima Y., Wang D.-H., Ogino K., Masuoka N., Makino H. Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice. Biochim. Biophys. Acta 2010, 1802:240-246.
35. Konrad R.J., Mikolaenko I., Tollar J.F., Liu K., Kudloww J.E. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic β-cell O-GlcNAc-selective N-acetyl-β-d-glucosaminidase. Biochem. J. 2011, 356:31-41.
36. Hwang I., Lee J., Huh J.Y., Park J., Lee H.B., Ho Y.S., Ha H. Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 2012, 61:728-738.
37. Tesch G.H., Nikolc-Paterson D.J. Recent insights into experimental mouse models of diabetic nephropathy. Nephron-Exper. Nephrol. 2006, 104:e57-e62.
38. Sunami R., Sudiyama H., Wang D.-H., Kobayashi M., Maesima Y., Yamasaki Y., Masuoka N., Ogawa N., Kira S., Makino H. Acatalasemia sensitizes renal tubular epithel cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am. J. Physiol-Renal Physiol. 2004, 286:F1030-F1038.
39. Kobayashi M., Sugiyama H., Wang D.-H., Toda N., Maeshima Y., Yamasaki Y., Masuoka N., Yamada M., Kira S., Makino H. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis. Kidney Int. 2005, 68:1018-1031.
40. Takiue K., Sugiyam H., Inoue T., Morinaga H., Kikumoto Y., Kitagawa M., Kiamura S., Maeshima Y., Wang D.-H., Masuoka N., Ogino K., Makino H. Acatalasemic mice are medley susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis. BMC Nephrol. 2012, 13(14).
41. Fukuoka N., Sugiyama H., Inoue T., Kikumoto Y., Takiue K.-I., Morinaga H., Nakao K., Maeshima Y., Asanuma M., Wang D.-H., Ogino K., Masuoka N., Makino H. Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice. Am. J. Nephrol. 2008, 28:661-668.
42. Góth L., Rass P., Pay A. Catalase enzyme mutations and their association with diseases. Mol. Diagn. 2004, 8:141-149.
43. Ogata M., Acatalasemia Hum. Genet 1991, 86:331-340.
44. Matsunaga T., Seger R., Höger L., Tiefenaur L., Hotzig W.H. Congenital acatalasemia. A study of neutrophil function after provocation with hydrogen peroxide. Pediat. Res. 1985, 19:1187-1195.
45. Delgado W.A., Calderon R. Acatalasia in two Peuvian siblings. J. Oral Pathol. Med. 1979, 8:358-368.
46. Perner H., Krenkel C., Lackner B., Hintner H., Hawranek T. Akatalasemie-Morbus Takahara. Hautarzt 1999, 50:590-592.
47. Wally V., Buchroithener B., Klausegger M., Laimer M., Hintner H., Bauer J.W. Acatalasemia: identicfication of a novel missense mutation. J. Invest. Dermatol. 2004, 122:A85-A85.
48. Pfügler G., Kaiser E. Acatalasia discovered by accident during disk operation. Arch. Orthopaed. Traumat. Surg. 1988, 107:189-190.
49. Góth L. Two cases of acatalasemia in Hungary. Clin. Chim. Acta 1992, 207:155-158.
50. Hamada Y., Kameyama Y., Izuka T., Ishizaki T., Nishiyama T., Isshiki A. Methemoglobinemia from hydrogen peroxide in a patient with acatalasemia. Anesthesiol. 2004, 101:247-248.
51. Aebi H., Bossi M., Cantz M., Matsubara S., Suter H. Acatalas(emia) in Switzerland. Hereditary Disorders of Erythrocyte Metabolism 1968, 41-91. Grune & Stratton, New York. E. Butler (Ed.).
52. Ogata M., Hayashi S., Takahara S. Estimation of the frequency of the recessive gene of acatalasemia in Japan. Acta Med. Okayama 1971, 25:193-198.
53. Parboosingh J.S., Rousseau M., Rogan F., Amit Z., Cherkow H., Johnson W.G., Manganaro F., Scipper N., Curran T.J., Stoessl J., Rouleau G.A. Absence of mutation in superoxide dismutase and catalase genes in patients with Parkinson's disease. Arch. Neurol. 1995, 52:1160-1163.
54. Góth L., Shemirani A., Kalmar T. A novel catalase mutation (a GA insertion) causes the Hungarian type of acatalasemia. Blood Cells Mol. Dis. 2000, 26:151-154.
55. Góth L., Rass P., Madarasi I. A novel catalase mutation detected by polymerase chain reaction-single strand conformation polymorphism, nucleotide sequencing, and Western blot analyses is responsible for the type C of Hungarian acatalasemia. Electrophoresis 2001, 22:49-51.
56. Góth L., Vitai M., Rass P., Sukei E., Pay A. Detection of a novel familial catalase mutation (Hungarian type D) and the possible risk of inherited catalase deficiency for diabetes mellitus. Electrophoresis 2005, 26:1646-1649.
57. Vitai M., Fatrai S., Rass P., Csordas M., Tarnai I. Simple PCR-heteroduplex,-SSCP mutation screening methods for detection of novel catalase mutations in Hungarian patients with type 2 diabetes mellitus. Clin. Chem. Lab. Med. 2005, 43:1349-1350.
58. Góth L. A novel catalase mutation (a G insertion in exon 2) causaes the type B of the Hungarian acatalasemia. Clin. Chim. Acta 2001, 311:161-163.
59. Kosa Z., Fejes Z., Nagy T., Csordas M., Simics E., Remenyik E., Goth L. Catalase -262C→T polymorphism in Hungarian vitiligo patients and in controls: further acatalasemia mutations in Hungary. Mol Biol. Rep. 2012, 39:4787-4795.
60. Takahara S. Acatalasemia in Japan. Hereditary Disorders of Erythrocyte Metabolism 1968, 21-40. Grune and Stratton, New York. E. Beutler (Ed.).
61. Crawford D.R., Mirault M.E., Moret R., Ybinden I., Ceritti P.A. Molecular defect in human acatalasia. Biochem. Biophys. Res. Com. 1988, 153:59-66.
62. Kishimoto Y., Murakami Y., Hayashi K., Takahara S., Sugimura T., Sekiya T. Detection of a common mutation of the catalase gene in Japanese acatalasemic patients. Hum. Genet. 1992, 88:487-490.
63. Hirono A., Sasaya-Hamada F., Kanno H., Fujji H., yoshida T., Miwa S. A novel human catalase mutation (358T-del) causing Japanese-type acatalasemia. Blood Cells Mol. Dis. 1995, 21:232-234.
64. Góth L., Nagy T. Acatalasemia and diabetes mellitus. Arch. Biochem. Biophys. 2012, 525:195-200.
65. Jermedy G. Hungarian register new and improved. British Med. J. 1994, 308:134-135.
66. Tirosh A., Shai I., Tekes- Manova D., Pereg D., Schochat T., Kochba I., Rudich A. Normal fasting plasma glucose levels and type 2 diabetes in young men. New Engl. J. Med. 2005, 353:1454-1462.
67. Góth L. Lipid and carbohydrate metabolism in acatalasemia. Clin. Chem. 2000, 46:564-566.
68. Góth L., Vitai M. The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human acatalasemic patients. Free Radic. Biol. Med. 2003, 35:882-888.
69. Góth L. Characterization of acatalasemia detected in two Hungarian sisters. Enzyme 1992, 46:252-258.
70. Góth L., Tóth Z., Tarnai I., Bérces M., Török P., Bigler W.N. Blood catalase activity in gestational diabetes is decreased but not associated with pregnancy complications. Clin. Chem. 2005, 51:2401-2404.
71. Góth L., Csordás M., Kósa Z., Simics E. A weak association of blood catalase activity and +22348C→T polymorphism of the catalase gene in Hungarian female vitiligo patients. Clin. Exper. Med. 2010, 4:1-7.
72. Góth L., Nagy T., Kósa Z., Fejes Z., Bhattoa H.P., Paragh G., Káplár M. Effects of rs769217 and rs10001179 polymorphisms of catalase gene on blood catalase, carbohydrate and lipid biomarkers in diabetes mellitus. Free Rad. Res. 2012, 46:124-1257.
73. Love I.N. Peroxide of Hydrogen as a remedial agent. JAMA 1888, 10:262-265.
74. Farr C.H. Physiological and biochemical responses to intravenous hydrogen peroxide in man. J. Adv. Med. 1988, 1:113-129.
75. Watt B.E., Proudfoot A.T., Vale J.A. Hydrogen peroxide poisoning. Toxicol. Rev. 2004, 23:51-57.
76. Reid C.J., Alock M., Penn D. Hydrogen peroxide - a party trick from the past?. Toxicol. Rev. 2011, 39:1004-1008.
77. Ogata M., Mizugaki J., Ueda K., Ikeda M. Activities of superoxide dismutase and glutathione peroxidase in the red blood cells of Japanese acatalasemia blood. Tohoku J. Exper. Med. 1977, 123:95-98.
78. Biological Antioxidant Capacity (MC436, Diacron International, Grosseto, Italy).
79. Wood C.S., Koepke J.I., Teng H., Boucher K.K., Katz S., Chang P., Terlecky L.J., Papanayotou I., Walton P.A., Terlecky S.R. Hypocatalasemic fibroblast accumulate hydrogen peroxide and display age-associated pathologies. Traffic 2006, 7:97-107.
80. Góth L., Bigler W.N. Catalase deficiency may complicate urate oxidase (rasburicase) therapy. Free Radic. Res. 2007, 41:953-955.
81. 2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J. 2009, 23:2065-2075.
82. Casp C.B., She J.X., McCormick W.T. Genetic association of the catalase gene(CAT) with vitiligo susceptibility. Pigment Cell Res. 2002, 15:62-66.
83. D'souza A., Kurien B.T., Rodgers R., Shenoi J., Kurono S., Matsumoto H., Hensley K., Nath S.K., Hal R., Scofield R.H. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med. Genet. 2008, 9:62.
84. Heales S.J.R. Catalase deficiency, diabetes and mitochondrial function. Lancet 2001, 357:414.
85. Szeinberg A., de Vries A., Pinkhas J., Djaldetti M., Ezra R. A dual hereditary red blood cell defect in one family: hypocatalasemia and glucose-6-phosphate dehydrogenase deficiency. Acta Genet. Med. Gemollol (Roma). 1963, 12:247-255.